ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,659.60
      -2.28%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.37
      0.31%
      Bitcoin
      57,277.87
      -0.12%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Global Blood Therapeutics Inc (GBT)

      7. Global Blood Therapeutics Inc (GBT) News

      GBT

      Global Blood Therapeutics (GBT)

      Global Blood Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GBT
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      06/15/20186:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      06/15/20182:30AMGlobeNewswire Inc.GBT Announces New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease (SCD) at 23rd European Hematology Associati...NASDAQ:GBTGlobal Blood Therapeutics Inc
      06/08/20188:30AMGlobeNewswire Inc.GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease (SCD) Program at Foundation for Sickle Cel...NASDAQ:GBTGlobal Blood Therapeutics Inc
      06/05/20184:05PMGlobeNewswire Inc.GBT Announces New Employment Inducement GrantsNASDAQ:GBTGlobal Blood Therapeutics Inc
      05/21/20184:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      05/17/201810:30AMGlobeNewswire Inc.GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at 23rd European Hematology Associ...NASDAQ:GBTGlobal Blood Therapeutics Inc
      05/07/20184:16PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GBTGlobal Blood Therapeutics Inc
      05/07/20184:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      05/07/20184:05PMGlobeNewswire Inc.GBT Reports Recent Business Progress and First Quarter 2018 Financial ResultsNASDAQ:GBTGlobal Blood Therapeutics Inc
      05/04/20188:30AMGlobeNewswire Inc.GBT Announces New Employment Inducement GrantsNASDAQ:GBTGlobal Blood Therapeutics Inc
      04/26/20184:27PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GBTGlobal Blood Therapeutics Inc
      04/26/20184:22PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GBTGlobal Blood Therapeutics Inc
      04/26/20184:13PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GBTGlobal Blood Therapeutics Inc
      04/19/20184:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      04/03/20184:05PMGlobeNewswire Inc.GBT Announces Participation at the H.C. Wainwright Global Life Sciences ConferenceNASDAQ:GBTGlobal Blood Therapeutics Inc
      04/03/20184:05PMGlobeNewswire Inc.GBT Announces New Employment Inducement GrantsNASDAQ:GBTGlobal Blood Therapeutics Inc
      03/20/20185:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      03/15/20184:05PMGlobeNewswire Inc.GBT Announces New Employment Inducement GrantsNASDAQ:GBTGlobal Blood Therapeutics Inc
      03/14/20185:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GBTGlobal Blood Therapeutics Inc
      03/12/20188:38AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GBTGlobal Blood Therapeutics Inc
      03/12/20188:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      03/12/20188:00AMGlobeNewswire Inc.Global Blood Therapeutics Announces Full Exercise of Underwriter’s Option to Purchase Additional SharesNASDAQ:GBTGlobal Blood Therapeutics Inc
      03/09/20185:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      03/08/201810:00PMGlobeNewswire Inc.Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common StockNASDAQ:GBTGlobal Blood Therapeutics Inc
      03/08/20184:14PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GBTGlobal Blood Therapeutics Inc
      03/08/20184:01PMGlobeNewswire Inc.Global Blood Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:GBTGlobal Blood Therapeutics Inc
      03/06/20188:00AMGlobeNewswire Inc.GBT Appoints Industry Leader David L. Johnson as Chief Commercial OfficerNASDAQ:GBTGlobal Blood Therapeutics Inc
      03/05/20185:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      03/05/20184:05PMGlobeNewswire Inc.GBT Announces New Employment Inducement GrantsNASDAQ:GBTGlobal Blood Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GBT

      Your Recent History

      NASDAQ
      ATHX
      Athersys
      Delayed Upgrade Clock